Vaccine, Partner

Vaccine Partner Valneva receives FDA approval for the World's first chikungunya vaccine using Albumedix' Recombumin®

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Albumedix, now part of Sartorius Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom India South Korea United States of America Canada Europe Japan

View original content:https://www.prnewswire.co.uk/news-releases/vaccine-partner-valneva-receives-fda-approval-for-the-worlds-first-chikungunya-vaccine-using-albumedix-recombumin-301995668.html

en | DE0007165607 | VACCINE | boerse | 67997949 |